| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 75,005 | 61,270 | 43,485 | | Cost of Revenue | 23,331 | 20,444 | 14,230 | | | Gross Profit | 51,674 | 40,826 | 29,255 | | | Operating Expenses | | Research Development | 26,787 | 22,445 | 15,340 | | Selling General and Administrative | 30,231 | 23,582 | 14,781 | | Non Recurring |
-
|
-
|
-
| | Others | 1,241 | 360 | 118 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (6,585) | (5,561) | (984) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,669 | 2,758 | 611 | | Earnings Before Interest And Taxes | (4,916) | (2,803) | (373) | | Interest Expense | 84 | 1,216 | 1,091 | | Income Before Tax | (5,000) | (4,019) | (1,464) | | Income Tax Expense | (47) | 455 | 52 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,953) | (4,474) | (1,516) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,953) | (4,474) | (1,516) | | Preferred Stock And Other Adjustments |
-
|
-
| (32) | | | Net Income Applicable To Common Shares | ($4,953) | ($4,474) | ($1,548) |
|
0.22% Nasdaq 
Income Statement
